Ownership history in Qube Research & Technologies Ltd · 9 quarters on record
This page tracks every 13F SEC filing in which Qube Research & Technologies Ltd reported a position in SILVERBACK THERAPEUTICS INC (SPRY). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | ADDED | 1,034,798 | +904,509 | +694.2% | 0.01% | $10.4M | $10.05 |
| 2024 Q4 | ADDED | 130,289 | +90,593 | +228.2% | 0.00% | $1.4M | $10.55 |
| 2024 Q3 | ADDED | 39,696 | +27,063 | +214.2% | 0.00% | $576K | $14.50 |
| 2024 Q1 | REDUCED | 12,633 | -64,736 | -83.7% | 0.00% | $129K | $10.22 |
| 2023 Q1 | ADDED | 77,369 | +48,532 | +168.3% | 0.00% | $504K | $6.51 |
| 2022 Q4 | ADDED | 28,837 | +12,412 | +75.6% | 0.00% | $246K | $8.53 |
| 2022 Q3 | REDUCED | 16,425 | -1,441 | -8.1% | 0.00% | $87K | $5.28 |
| 2022 Q2 | REDUCED | 17,866 | -1,618 | -8.3% | 0.00% | $76K | $4.24 |
| 2020 Q4 | INITIATED | 19,484 | — | — | 0.01% | $903K | $46.34 |
As of 2025 Q4 — sorted by position size